New flu shot for seniors passes early safety check
NCT ID NCT07421037
First seen Feb 19, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This early-stage study tested whether a new flu vaccine with an added booster (adjuvant) is safe for adults aged 65 and older. About 80 participants received the vaccine and were monitored for side effects over a year. The goal was to check for any immediate or long-term safety concerns before moving to larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yunxi County Center for Disease Control and Prevention
Shiyan, Hubei, China
Conditions
Explore the condition pages connected to this study.